Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

2.

Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.

Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E.

BMC Cardiovasc Disord. 2016 May 31;16:115. doi: 10.1186/s12872-016-0283-6.

3.

The Impacts of In-Hospital Invasive Strategy on Long-Term Outcome in Elderly Patients with Non-ST-Elevation Myocardial Infarction.

Huang SS, Leu HB, Lu TM, Wu TC, Chen YH, Chen JW, Lin SJ, Chan WL.

Zhonghua Minguo Xin Zang Xue Hui Za Zhi. 2013 Mar;29(2):115-23.

4.

National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011.

Zhang L, Li J, Li X, Nasir K, Zhang H, Wu Y, Hu S, Wang Q, Downing NS, Desai NR, Masoudi FA, Spertus JA, Krumholz HM, Jiang L; China PEACE Collaborative Group.

PLoS One. 2016 Apr 8;11(4):e0150806. doi: 10.1371/journal.pone.0150806. eCollection 2016.

5.

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?

Silva PG, Ribeiro HB, Baruzzi AC, Silva EE.

Arq Bras Cardiol. 2016 Mar;106(3):236-46. doi: 10.5935/abc.20160042. English, Portuguese.

6.

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.

Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Lee WK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Chae SC; Korea Acute Myocardial Infarction Registry Investigators.

Korean J Intern Med. 2016 Mar;31(2):267-76. doi: 10.3904/kjim.2014.268. Epub 2015 Dec 23.

7.
8.

Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population.

Salo PP, Vaara S, Kettunen J, Pirinen M, Sarin AP, Huikuri H, Karhunen PJ, Eskola M, Nikus K, Lokki ML, Ripatti S, Havulinna AS, Salomaa V, Palotie A, Nieminen MS, Sinisalo J, Perola M.

PLoS One. 2015 Oct 28;10(10):e0140576. doi: 10.1371/journal.pone.0140576. eCollection 2015.

9.

Chemiluminometric Immunosensor for High-Sensitivity Cardiac Troponin I Employing a Polymerized Enzyme Conjugate as a Tracer.

Lim GS, Seo SM, Paek SH, Kim SW, Jeon JW, Kim DH, Cho IH, Paek SH.

Sci Rep. 2015 Oct 7;5:14848. doi: 10.1038/srep14848.

10.

Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar.

Farag M, Patel H, Gorog DA.

Drug Des Devel Ther. 2015 Jul 22;9:3801-9. doi: 10.2147/DDDT.S68391. eCollection 2015. Review.

11.

No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.

Poldervaart JM, Röttger E, Dekker MS, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, van 't Hof AW, Mosterd A, Hoes AW.

PLoS One. 2015 Jul 15;10(7):e0132000. doi: 10.1371/journal.pone.0132000. eCollection 2015.

12.

National Quality Assessment of Early Clopidogrel Therapy in Chinese Patients With Acute Myocardial Infarction (AMI) in 2006 and 2011: Insights From the China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study.

Zhang L, Desai NR, Li J, Hu S, Wang Q, Li X, Masoudi FA, Spertus JA, Nuti SV, Wang S, Krumholz HM, Jiang L; China PEACE Collaborative Group.

J Am Heart Assoc. 2015 Jul 10;4(7). pii: e001906. doi: 10.1161/JAHA.115.001906.

13.

Impact of treatment algorithms on the prescribing of antithrombotic therapy in patients with suspected acute coronary syndrome - a prospective audit.

Cameron AC, McCallum L, Gardiner T, Darroch C, Walters MR, Oldroyd KG.

Br J Clin Pharmacol. 2015 Nov;80(5):1176-84. doi: 10.1111/bcp.12714. Epub 2015 Sep 25.

PMID:
26147691
14.

Combined ECG, Echocardiographic, and Biomarker Criteria for Diagnosing Acute Myocardial Infarction in Out-of-Hospital Cardiac Arrest Patients.

Lee SE, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B.

Yonsei Med J. 2015 Jul;56(4):887-94. doi: 10.3349/ymj.2015.56.4.887.

15.

Reduction of QTD--A Novel Marker of Successful Reperfusion in NSTEMI. Pathophysiologic Insights by CMR.

Jensen CJ, Lusebrink S, Wolf A, Schlosser T, Nassenstein K, Naber CK, Sabin GV, Bruder O.

Int J Med Sci. 2015 May 3;12(5):378-86. doi: 10.7150/ijms.11224. eCollection 2015.

16.

Long-term prognosis of patients with acute non-ST-segment elevation myocardial infarction undergoing different treatment strategies.

Zhang B, Shen DP, Zhou XC, Liu J, Huang RC, Wang YE, Chen AM, Zhu YR, Zhu H.

Chin Med J (Engl). 2015 Apr 20;128(8):1026-31. doi: 10.4103/0366-6999.155071.

17.

Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry.

Numasawa Y, Kohsaka S, Miyata H, Kawamura A, Noma S, Suzuki M, Nakagawa S, Momiyama Y, Naito K, Fukuda K.

PLoS One. 2015 Apr 14;10(4):e0124399. doi: 10.1371/journal.pone.0124399. eCollection 2015.

18.

The effect of admission at weekends on clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome and its contributing factors.

Kim HJ, Kim KI, Cho YS, Kang J, Park JJ, Oh IY, Yoon CH, Suh JW, Youn TJ, Chae IH, Choi DJ.

J Korean Med Sci. 2015 Apr;30(4):414-25. doi: 10.3346/jkms.2015.30.4.414. Epub 2015 Mar 19.

19.

Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome.

Laborde CM, Mourino-Alvarez L, Posada-Ayala M, Alvarez-Llamas G, Serranillos-Reus MG, Moreu J, Vivanco F, Padial LR, Barderas MG.

Metabolomics. 2014;10(3):414-424. Epub 2013 Oct 26.

20.

Value of heart-type fatty acid-binding protein (H-FABP) for emergency department patients with suspected acute coronary syndrome.

Banu KY, Niyazi OD, Erdem C, Dpekçi Afşin DH, Ozlem U, Yasemin C, Afsin I.

Afr Health Sci. 2014 Sep;14(3):757-62. doi: 10.4314/ahs.v14i3.36.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk